NCT02586181

Brief Summary

The standard recommendation to prevent osteoporosis is to supplement low doses of vitamin D and calcium. Hyperhomocysteinemia has been related to increased risk of osteoporosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2009

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
4.3 years until next milestone

First Submitted

Initial submission to the registry

October 21, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 26, 2015

Completed
Last Updated

April 4, 2019

Status Verified

April 1, 2019

Enrollment Period

1.9 years

First QC Date

October 21, 2015

Last Update Submit

April 2, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in bone formation markers

    Concentrations of bone formation markers in plasma \[OC (ng/ml), BAP (U/L)\]: are measured: if all are increased indicate enhanced bone formation

    baseline, 6 and 12 months

Secondary Outcomes (8)

  • Changes in plasma choline and betaine

    baseline and aftter 12 months

  • Changes in global DNA methylation

    baseline and after 12 months

  • Changes in gene-specific gene methylation

    baseline and after 12 months

  • Changes in TMAO

    baseline and after 6 and 12 months

  • Changes in phospholipid concentration in plasma

    baseline and after 12 months

  • +3 more secondary outcomes

Study Arms (2)

Vitamin D and Calcium

PLACEBO COMPARATOR

a combination of dietary supplement including "all" 1200 IE Vitamin D3 plus 800 mg Calcium Carbonate

Dietary Supplement: Vitamin D and Calcium

Vitamin D, Calcium, Vitamins B9, B6, B12

EXPERIMENTAL

a combination of dietary supplement including "all" 1200 IE Vitamin D3 plus 800 mg Calcium Carbonate plus 0,5mg Folic acid, 50 mg B6, 0,5 mg B12

Dietary Supplement: Vitamin D, Calcium, Vitamins B9, B6, B12

Interventions

Vitamin D and CalciumDIETARY_SUPPLEMENT

a combination of dietary supplement including "all" 1200 IE Vitamin D3 plus 800 mg Calcium Carbonate 1200 IE Vitamin D3 plus 800 mg Calcium Carbonate Arm: Experimental: Vitamin D, Calcium, Vitamins B9, B6, B12 1200 IE Vitamin D3 plus 800 mg Calcium Carbonate plus 0,5mg Folic acid, 50 mg B6, 0,5 mg B12

Vitamin D and Calcium

a combination of dietary supplement including "all" 1200 IE Vitamin D3 plus 800 mg Calcium Carbonate plus 0,5mg Folic acid, 50 mg B6, 0,5 mg B12

Vitamin D, Calcium, Vitamins B9, B6, B12

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age\> 50 years,
  • male and female

You may not qualify if:

  • renal dysfunction,
  • recent stroke or coronary event within the last 3 months,
  • current cancer,
  • antifolate treatment,
  • ileum resection,
  • existing B vitamins supplementation,
  • megaloblastic anemia,
  • osteoporotic patients treated with pharmacological doses of vitamin D or antiosteoporotic drugs.
  • Termination criteria were:
  • indication for a high-dose vitamin B supplementation,
  • coronary or vascular event,
  • or surgical procedures during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Saarland

Homburg, Saarland, 66424, Germany

Location

Related Publications (5)

  • Kirsch SH, Herrmann W, Kruse V, Eckert R, Graber S, Geisel J, Obeid R. One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans. Clin Chem Lab Med. 2015 Feb;53(3):445-52. doi: 10.1515/cclm-2014-0540.

  • Hubner U, Geisel J, Kirsch SH, Kruse V, Bodis M, Klein C, Herrmann W, Obeid R. Effect of 1 year B and D vitamin supplementation on LINE-1 repetitive element methylation in older subjects. Clin Chem Lab Med. 2013 Mar 1;51(3):649-55. doi: 10.1515/cclm-2012-0624.

  • Herrmann W, Kirsch SH, Kruse V, Eckert R, Graber S, Geisel J, Obeid R. One year B and D vitamins supplementation improves metabolic bone markers. Clin Chem Lab Med. 2013 Mar 1;51(3):639-47. doi: 10.1515/cclm-2012-0599.

  • Obeid R, Hubner U, Bodis M, Graeber S, Geisel J. Effect of adding B-vitamins to vitamin D and calcium supplementation on CpG methylation of epigenetic aging markers. Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):411-417. doi: 10.1016/j.numecd.2017.12.006. Epub 2017 Dec 29.

  • Obeid R, Awwad HM, Rabagny Y, Graeber S, Herrmann W, Geisel J. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism. Am J Clin Nutr. 2016 Mar;103(3):703-11. doi: 10.3945/ajcn.115.121269. Epub 2016 Feb 10.

MeSH Terms

Interventions

Vitamin DCalciumVitamin B 12

Intervention Hierarchy (Ancestors)

SecosteroidsSteroidsFused-Ring CompoundsPolycyclic CompoundsMetals, Alkaline EarthElementsInorganic ChemicalsMetalsBlood Coagulation FactorsBiological FactorsCorrinoidsTetrapyrrolesPyrrolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingMacrocyclic Compounds

Study Officials

  • Rima Obeid, PhD

    Universität des Saarlandes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. (apl.) Dr.

Study Record Dates

First Submitted

October 21, 2015

First Posted

October 26, 2015

Study Start

August 1, 2009

Primary Completion

July 1, 2011

Study Completion

July 1, 2011

Last Updated

April 4, 2019

Record last verified: 2019-04

Locations